Everything You Need to Know About Goodpasture syndrome for Step 1

Goodpasture syndrome is one of those “Step classics” that shows up whenever the question stem combines hemoptysis + hematuria and asks you to pick the autoantibody or the best confirmatory test. It’s a tight, testable package: a specific target antigen, a characteristic immunofluorescence pattern, and a life-threatening clinical course if you miss it.

Where it fits (and why it’s tested)

Goodpasture syndrome is an autoimmune anti–glomerular basement membrane (anti-GBM) disease that causes:

• Rapidly progressive glomerulonephritis (RPGN) (a nephritic syndrome)
• Pulmonary hemorrhage from alveolar basement membrane injury

Even though it can present with interstitial findings on imaging, Step tends to group it with “pulmonary-renal syndromes” and diffuse alveolar hemorrhage differentials—often in the same universe as GPA/MPA.

---

Definition (Step-friendly)

Goodpasture syndrome = Type II hypersensitivity due to IgG autoantibodies against the $\alpha 3$ chain of type IV collagen in:

• Glomerular basement membrane (kidney)
• Alveolar basement membrane (lung)

Key Step phrase: “Anti-GBM antibodies to type IV collagen.”

---

Pathophysiology (what’s actually happening)

The antigen

• Type IV collagen, specifically the $\alpha 3$ chain
• Found in basement membranes of glomeruli and alveoli

The immune mechanism

• Type II hypersensitivity (antibody-mediated)
• IgG binds basement membrane → complement activation and inflammation
• In kidneys: crescentic GN (RPGN)
• In lungs: capillaritis → alveolar hemorrhage

Why “linear” matters

Because antibodies bind a fixed, evenly distributed antigen along the basement membrane, immunofluorescence shows:

• Linear IgG (and often C3) deposition along GBM

This contrasts with immune complex diseases (granular) and ANCA vasculitides (pauci-immune).

---

Clinical presentation (what you’re expected to recognize)

Classic triad-ish pattern (in real life and on Step)

• Hemoptysis (often with dyspnea)
• Hematuria (cola-colored urine is a nephritic clue)
• Rising creatinine (RPGN)

Pulmonary findings

• Diffuse alveolar hemorrhage
  • Hemoptysis may be absent early (patients can just be hypoxic/anemic)
• Iron-deficiency anemia can develop due to recurrent hemorrhage
• Imaging can show bilateral patchy alveolar opacities (can look like edema, infection)

Renal findings (nephritic)

• Hematuria with RBC casts
• Proteinuria (usually subnephrotic)
• Hypertension may appear as renal failure progresses
• Rapid decline in kidney function over days to weeks

High-yield trigger associations

Step questions often mention a precipitating factor that “unmasks” pulmonary hemorrhage:

• Smoking
• Recent respiratory infection
• Hydrocarbon exposure (less common but classic board-style)

---

Diagnosis (the board-style workflow)

1) Initial labs you’ll see in the stem

• UA: hematuria + RBC casts
• CBC: anemia (blood loss), possible inflammation
• BMP: rising BUN/Cr
• Consider ABG if hypoxic

2) Serology (fast and testable)

• Anti-GBM antibodies in serum are strongly supportive

3) Definitive diagnosis: biopsy + immunofluorescence

Kidney biopsy is the classic confirmatory test:

• Light microscopy: crescentic glomerulonephritis (RPGN)
• Immunofluorescence: linear IgG along GBM

Pattern recognition table (high yield)

4) The “pivotal distractor” detail: ANCAs

Goodpasture is not an ANCA-associated vasculitis, but some patients can have both anti-GBM and ANCA positivity (classically MPO-ANCA). On exams, the core identity is still linear IF + anti-GBM.

---

Treatment (what to do, and why)

Management is urgent because kidney damage can become irreversible.

Core regimen (memorize this trio)

1. Plasmapheresis
   • Removes circulating anti-GBM antibodies
2. High-dose corticosteroids
   • Rapid immunosuppression to reduce inflammation
3. Cyclophosphamide (or sometimes rituximab in practice; Step usually wants cyclophosphamide)
   • Prevents new antibody production by suppressing B cells

Supportive/bridge care

• Oxygen/ventilatory support if severe hemorrhage
• Dialysis if renal failure is advanced

Prognostic pearl (Step-relevant)

• Prognosis is worse with severe renal dysfunction at presentation, especially if already dialysis-dependent or with extensive crescent formation.

---

High-yield “Step 1 style” associations & memory hooks

The two-word giveaway

• “Hemoptysis + hematuria” = think Goodpasture first, then differentiate from ANCA vasculitis.

What to match quickly

• Target antigen: type IV collagen $\alpha 3$ chain
• Hypersensitivity: Type II
• IF: Linear IgG (± C3)
• LM: crescents (RPGN)

Don’t confuse with these

• Post-strep GN: granular IF (“starry sky”), low complement
• IgA nephropathy: episodic hematuria after URI, mesangial IgA deposition
• Anti-dsDNA lupus nephritis: granular IF, multi-system lupus findings
• GPA/MPA: ANCA-positive, pauci-immune IF

---

First Aid cross-references (what to flip to)

These topics are tested together across organ systems, so it helps to cross-link them the way First Aid does:

• Pulmonary–renal syndromes / diffuse alveolar hemorrhage
• Nephritic syndromes and RPGN (crescentic GN)
• Type II hypersensitivity
• Immunofluorescence patterns: linear vs granular vs pauci-immune
• ANCA-associated vasculitides (GPA/MPA) as major differentials

(Page numbers vary by edition, but these headings are consistent across recent First Aid versions.)

---

Rapid review (last-minute checklist)

• Autoantibody: anti-GBM (anti–type IV collagen, $\alpha 3$)
• Organs: lung + kidney
• Symptoms: hemoptysis, dyspnea, hematuria, rising creatinine
• Urine: RBC casts (nephritic)
• Biopsy IF: linear IgG
• Treatment: plasmapheresis + steroids + cyclophosphamide
• Big differential clue: ANCA vasculitis is pauci-immune, not linear